Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005

Ian G Barr; Aeron C Hurt; Pina Iannello; C Tomasov; Nicola Deed; Naomi Komadina

Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005

Ian G Barr, Aeron C Hurt, Pina Iannello, C Tomasov, Nicola Deed, Naomi Komadina

Research output: Contribution to journal › Article › Research › peer-review

Abstract

The prevention and control of disease caused by seasonal and potential pandemic influenza viruses is currently managed by the use influenza vaccines and antivirals. The adamantanes (amantadine and rimantadine) were the first antivirals licensed for use against influenza A viruses and have been used extensively in some countries. Since the early 2000s increased resistance to these drugs has been reported especially in the A(H3) viruses. In this study we analysed recent human influenza A strains isolated in Australia and regionally for evidence of resistance to adamantanes and found evidence of significant resistant emerging during 2005. (c) 2006 Elsevier B.V. All rights reserved.

Original language	English
Pages (from-to)	112 - 117
Number of pages	6
Journal	Antiviral Research
Volume	73
Issue number	2
Publication status	Published - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{dff78ebe76894f8e993420b3b48ea9c0,

title = "Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005",

abstract = "The prevention and control of disease caused by seasonal and potential pandemic influenza viruses is currently managed by the use influenza vaccines and antivirals. The adamantanes (amantadine and rimantadine) were the first antivirals licensed for use against influenza A viruses and have been used extensively in some countries. Since the early 2000s increased resistance to these drugs has been reported especially in the A(H3) viruses. In this study we analysed recent human influenza A strains isolated in Australia and regionally for evidence of resistance to adamantanes and found evidence of significant resistant emerging during 2005. (c) 2006 Elsevier B.V. All rights reserved.",

author = "Barr, {Ian G} and Hurt, {Aeron C} and Pina Iannello and C Tomasov and Nicola Deed and Naomi Komadina",

year = "2007",

language = "English",

volume = "73",

pages = "112 -- 117",

journal = "Antiviral Research",

issn = "0166-3542",

publisher = "Elsevier BV",

number = "2",

}

TY - JOUR

T1 - Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005

AU - Barr, Ian G

AU - Hurt, Aeron C

AU - Iannello, Pina

AU - Tomasov, C

AU - Deed, Nicola

AU - Komadina, Naomi

PY - 2007

Y1 - 2007

N2 - The prevention and control of disease caused by seasonal and potential pandemic influenza viruses is currently managed by the use influenza vaccines and antivirals. The adamantanes (amantadine and rimantadine) were the first antivirals licensed for use against influenza A viruses and have been used extensively in some countries. Since the early 2000s increased resistance to these drugs has been reported especially in the A(H3) viruses. In this study we analysed recent human influenza A strains isolated in Australia and regionally for evidence of resistance to adamantanes and found evidence of significant resistant emerging during 2005. (c) 2006 Elsevier B.V. All rights reserved.

AB - The prevention and control of disease caused by seasonal and potential pandemic influenza viruses is currently managed by the use influenza vaccines and antivirals. The adamantanes (amantadine and rimantadine) were the first antivirals licensed for use against influenza A viruses and have been used extensively in some countries. Since the early 2000s increased resistance to these drugs has been reported especially in the A(H3) viruses. In this study we analysed recent human influenza A strains isolated in Australia and regionally for evidence of resistance to adamantanes and found evidence of significant resistant emerging during 2005. (c) 2006 Elsevier B.V. All rights reserved.

UR - http://<Go to ISI>://000244385800004

M3 - Article

SN - 0166-3542

VL - 73

SP - 112

EP - 117

JO - Antiviral Research

JF - Antiviral Research

IS - 2

ER -

Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005

Abstract

UN SDGs

Other files and links

Cite this